Lucien A. Aarden

11.1k citations
101 papers · 9.1k indexed · 3 hit papers · h-index 45
Topics
Monoclonal and Polyclonal Antibodies Research (30 papers)T-cell and B-cell Immunology (28 papers)Immune Cell Function and Interaction (24 papers)

In The Last Decade

Lucien A. Aarden

101 papers receiving 8.8k citations

Hit Papers

Oncogene-Induced Senescence Relayed by ...198720262000201320081987200750010001.5k

Peers

Lucien A. Aarden
Comparison fields: 5 of 132
  • Immunology 4.4k
  • Molecular Biology 2.4k
  • Radiology, Nuclear Medicine and Imaging 1.6k
  • Physiology 1.3k
  • Oncology 1.2k
Replace Pierre Galanaud with:
Pierre Galanaud France
Angelo A. Manfredi Italy
Susumu Ikehara Japan
Massimo Gadina United States
David J. Rawlings United States
Reinhard Voll Germany
Jeffrey L. Platt United States
Scott S. Zamvil United States
Mikael Jondal Sweden
Claudia Mauri United Kingdom
Lucien A. Aarden relative to Pierre Galanaud France Pierre Galanaud's profile →
Citations per field
00.5×3.9×
Pierre Galanaud · 1×
Citations per year

Countries citing papers authored by Lucien A. Aarden

Since Specialization
Citations

This map shows the geographic impact of Lucien A. Aarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucien A. Aarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucien A. Aarden more than expected).

Fields of papers citing papers by Lucien A. Aarden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucien A. Aarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucien A. Aarden. The network helps show where Lucien A. Aarden may publish in the future.

Co-authorship network of co-authors of Lucien A. Aarden

This figure shows the co-authorship network connecting the top 25 collaborators of Lucien A. Aarden. A scholar is included among the top collaborators of Lucien A. Aarden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucien A. Aarden. Lucien A. Aarden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 54
2 130
3 20
4 154
5 24
6 28
7 20
8 46
9
4-Hydroxy-oxyphenbutazone is a potent inhibitor of cytokine production.
4
10 4
11 7
12 95
13 13
14 17
15 17
16 11
17 154
18 204
19 2
20 68

About Lucien A. Aarden

Lucien A. Aarden is a scholar working on Immunology, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 101 papers that have together received 9.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (30 papers), T-cell and B-cell Immunology (28 papers) and Immune Cell Function and Interaction (24 papers). The work is most often cited by research in Immunology (4.4k citations), Hematology (977 citations) and Rheumatology (1.2k citations). Lucien A. Aarden has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Els R. de Groot, Maarten Helle, Peter M. Lansdorp, Gertjan Wolbink, Daniel S. Peeper, Wolter J. Mooi, Chrysiis Michaloglou, Liesbeth C.W. Vredeveld, Remco van Doorn and Sirith Douma. Their work appears in journals such as Nature, Science and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026